Loading...
Pacific Biosciences of California Community
NasdaqGS:PACB Community- 2 Narratives written by author
- 0 Comments on narratives written by author
- 49 Fair Values set on narratives written by author
Community Investing Ideas
Long-read Sequencing And Genomics Trends Will Expand Market Potential
Key Takeaways Expanding adoption in global genomics projects and clinical labs is boosting recurring revenue streams, margin stability, and market diversification. Technical innovation and cost discipline are strengthening competitive leadership, reducing expenses, and supporting long-term earnings growth and sustainability.Read more
0users have liked this narrative
0users have commented on this narrative
30users have followed this narrative
AN
US$2.23
26.7% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
13.34% p.a.
Profit Margin
15.7%
Future PE
31.6x
Share price in 2028
US$2.76
Vega Shipments And Multi-Omics Trends Will Fuel Genomics Breakthroughs
Key Takeaways Accelerated adoption of new platforms and technologies is expanding PacBio's user base, international reach, and revenue diversification opportunities. Advances in product offerings and strategic partnerships are enhancing margins, market positioning, and access to high-growth clinical and precision medicine segments.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$3
45.7% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
21.66% p.a.
Profit Margin
14.21%
Future PE
37.52x
Share price in 2028
US$3.78